Negative Pressure Wound Therapy Market Size, Share and Trends 2026 to 2035

Revenue, 2025

USD 2.87 Bn

Forecast Year, 2035

USD 5.40 Bn

CAGR, 2026 - 2035

6.52%

Report Coverage

Global

What is the Negative Pressure Wound Therapy Market Size?

The global negative pressure wound therapy market size is calculated at USD 2.87 billion in 2025 and is predicted to increase from USD 3.06 billion in 2026 to approximately USD 5.40 billion by 2035, expanding at a CAGR of 6.52% from 2026 to 2035.

Negative Pressure Wound Therapy Market Key Takeaways

• The global negative pressure wound therapy market was valued at USD 2.87billion in 2025.
• It is projected to reach USD 5.10 billion by 2035.
• The market is expected to grow at a CAGR of 6.52% from 2026 to 2035.
• North America dominated the negative pressure wound therapy market with revenue share of 39% in 2025.
• Asia Pacific is estimated to be the fastest growing during the forecast period of 2026-2035.
• By product type, the conventional NPWT devices segment dominated the market in 2025.
• By product type, the single-use NPWT devices segment is expected to be the fastest growing during the forecast period.
• By wound type, the chronic wounds segment dominated the market in 2025.
• By wound type, the acute wounds segment is expected to be the fastest growing during the forecast period.
• By end-user type, the hospitals segment dominated the market in 2025.
• By end-user type, the home healthcare segment is estimated to be the fastest growing during the forecast period.

Market Overview

The negative pressure wound therapy market includes a segment of the advanced wound care industry focused on the production, distribution, and sales of negative pressure wound therapy (NPWT) devices. Negative pressure wound therapy (NPWT) is used to improve the physiology of wound healing by the application of sub-atmospheric pressure to promote granulation tissue and reduce inflammatory exudate. It is used to treat difficult wounds that are at risk of non-healing, like skin grafts or diabetic foot ulcers. The benefits of negative pressure wound therapy (NPWT) include minimization of inflammation, easy growth of new tissue, and support for wound closure. It helps to improve blood circulation, reduces swelling, stimulates antibacterial actions by preventing infections, drains excess fluid from the wound bed, improves quality of life, nursing costs savings, less necessity of surgeries, less wound dressing changes, and earlier hospital discharge.

Artificial Intelligence: The Next Growth Catalyst in Negative Pressure Wound Therapy

AI is transforming the negative pressure wound therapy industry by enabling technological evolution, which enables predictive therapeutic modeling. In this context, AI algorithms synthesize complex patient datasets to forecast healing milestones and preemptively identify high-risk variables, such as bioburden escalation or chronic stasis. Consequently, providers can transition to dynamic treatment protocols that optimize resource allocation, mitigate the risk of adverse clinical outcomes, and enhance the overall cost-effectiveness of wound care delivery.

Negative Pressure Wound Therapy Market Growth Factors

• Use of negative pressure wound therapy helps to reduce or minimize inflammation, redness, or swelling and to decrease the number of bacteria.
• It helps to promote a moist wound-healing environment, improve the growth of new tissue, support wound closure, improve blood circulation, stimulate antibacterial action, and prevent infections, which contributes to the growth of the negative pressure wound therapy market.
• It helps to improve quality of life, saves nursing costs, fewer necessities of surgeries, fewer wound dressing changes, and earlier hospital discharge, which helps the growth of the market.
• It is used as a supplement to flap or skin graft procedures, dehisced and subacute incisions, open and chronic wounds, pressure ulcers, acute surgical and traumatic wounds, and meshed grafts, these factors help to the growth of the market.

Key factors influencing future market trends

• Development of User-Friendly and Portable Solutions: More clients are looking for NPWT devices that can be used at home and are easy to manage. They allow patients to be treated in other locations and not solely in hospitals. Having a portable NPWT system supports patients and their caregivers, since wound management can occur at home or in an outpatient clinic.
• Increasing Investment in Healthcare: An increase in investments in healthcare and wound care technologies in emerging countries is boosting the growth of NPWT. Both the government and private sectors are promoting new and advanced approaches in caring for wounds. As a result, more clinics can use modern wound care equipment and treatment.
• Outpatient Care for Management of the Illness: More patients are now attending appointments outside of the hospital and at their homes. As a result, more people are looking for NPWT devices that can be utilized safely and correctly around the home. Shorter hospitalization, less cost for healthcare, and greater comfort for patients during wound recovery are all benefits of ambulatory NPWT.

Market Outlook

• Market Growth Overview: The negative pressure wound therapy market is expected to grow significantly between 2025 and 2034, driven by the growing number of chronic wounds, rising patient awareness, supportive government policies, and aging populations.
• Sustainability Trends: Sustainability trends involve a shift to home and ambulatory care, integration of sensors for real-time data, enhancing diagnosis, treatment planning, and addressing chronic wound burden.
• Major Investors: Major investors in the market include Solventum (formerly 3M's healthcare arm), Smith+Nephew, Mölnlycke Health Care, Convatec, and Cardinal Health.
• Startup Economy: The startup economy is focused on portable and single-use devices, integration of smart technology, and exploring next-generation biomaterials.

Market Scope

Market Dynamics

Drivers

Rising senior population

In the senior population, there is a prevalence of pressure ulcers, also known as pressure sores, bedsores, and decubitus ulcers. These are localized injuries to the underlying structures or the skin that need negative pressure wound therapy for treatment. In the senior population, incidents and prevalence rates are high because of multifactorial risk factors like physiological changes, medications affecting the skin, nutritional habits, changes in functional status, and comorbidities. As the senior population increases, the prevalence of chronic diseases also increases. Senior individuals are more open to chronic diseases, including heart disease, cancers, and diabetes. These factors help to the growth of the negative pressure wound therapy market.

Restraint

Contraindications and complications of the negative pressure wound therapy (NPWT)

Negative pressure wound therapy may be unsuitable for some wounds, including wounds because of skin cancer, inflamed bones (Osteomyelitis), eschar, dead or necrotic tissue that has not been cleaned, and tunnels or fistulas to body cavities and organs. The disadvantages of negative pressure wound therapy include initial pain because of the application of a negative pressure wound therapy device, and it is necessary to connect to the unit for a day at least 22 hours. The non-healing wound can require potentially more intrusive treatment than negative pressure wound therapy, and the therapy is not always effective. These complications may restrict the growth of the negative pressure wound therapy market.

Opportunities

Advanced technologies

Improvement in the negative pressure wound therapy for wound healing encouragements in orthopedic and traumatic wounds. Use of NPWTi-d (Negative pressure wound therapy instillation and dwell time for the management of orthopedics and traumatic wounds that provides unique challenges. Development of its applications and cost-effective analysis are guidelines based on randomized and longitudinal controlled research trials. These factors help to the growth of the negative pressure wound therapy market.

Use of disposable and portable models

The use of disposable and portable models for negative pressure wound therapy has many benefits, including minimizing risks of infections and eliminating the necessity of sterilizations, maintenance, and cleaning. Lack of manpower and time for healthcare sectors to reprocess medical products, which is helpful for healthcare professionals to use disposable and portable models. Disposable devices save healthcare professionals time and effort. Portable models help patients to take treatments at home. These factors are helpful for the growth of the negative pressure wound therapy market.

Segment Insights

Product Type Insights

The conventional NPWT devices segment dominated the market in 2024. In conventional NPWT-type devices, foam dressing is placed above the wound, which is sealed with impervious and an adhesive film and is connected to a vacuum pump, which creates negative pressure and removes air from the dressing. Conventional NPWT devices are ideal for deep, large wounds or heavily exudating wounds as they may manage fluid which is in large amounts. The adoption of conventional NPWT devices is increasing globally. It is useful for reducing costs and helps with earlier hospital discharges. These factors help to the growth of the segment and contribute to the growth of the negative pressure wound therapy market.

The single-use NPWT devices segment is expected to grow the fastest during the forecast period. The single-use NPWT devices are disposable, lightweight, and smaller. This device provides an effective and safe alternative to conventional negative pressure wound therapy. It helps to reduce complication rates of closed surgical incisions and provides healing of select open wounds. These devices are designed for home care use, and they can be used for primary treatment options. These factors help to the growth of the segment and contribute to the growth of the negative pressure wound therapy market.

Wound Type Insights

The chronic wounds segment dominated the market in 2024. In the chronic wound type, negative pressure wound therapy is used. This inflamed wound or chronic wound type is regularly cleaned by healthcare professionals who remove infected or dead tissue also and the treatment is known as debridement. Chronic wounds include infected cuts, large burns, deep ulcers, pressure ulcers, diabetic ulcers, arterial ulcers, and venous ulcers. For these certain wounds negative pressure wound therapy is recommended. These factors help to the growth of the segment and contribute to the growth of the negative pressure wound therapy market.

The acute wounds segment is estimated to be the fastest growing during the forecast period. When acute wounds are not covered or closed by primary intention because of swelling or skin tension, active infections, and risk of infections, negative pressure wound therapy is recommended for treatment. Acute wounds include traumatic burns or injuries and surgical incisions. The use of negative pressure wound therapy for acute wounds has grown increasingly popular. These factors help to the growth of the segment and contribute to the growth of the negative pressure wound therapy market.

End-use Type Insights

The hospitals segment dominated the negative pressure wound therapy market in 2024. Negative pressure wound therapy is used for the treatment of complex wounds and is now commonplace in outpatient and various clinical settings and hospitals. The use of negative pressure wound therapy in hospitals is because of the duration of the treatments, size of the wounds, number of debridements, and length of hospital stays. In hospitals for acute wound and chronic wound treatment purposes, negative pressure wound therapy is used. These chronic wound and acute wound types are the key factors for the use of this therapy in hospitals. An increasing number of hospitals leads to growth in the market. These factors help the growth of the segment and contribute to the growth of the market.

The home healthcare end-use type segment is expected to grow the fastest during the forecast period. Negative pressure wound therapy is a portable device that is used for patients to heal at home. Mostly for patients who suffer from chronic disease, there is a high use of home-based healthcare negative pressure wound therapy. In diabetic wound salvage and peripheral artery disease, there is the use of home-based negative pressure wound therapy. It is also helpful for the chronic and acute diseases. This home-based negative pressure wound therapy minimizes the risks of hospitalization. These factors help to the growth of the segment and contribute to the growth of the negative pressure wound therapy market.

Regional Insights

What is the U.S. Negative Pressure Wound Therapy Market Size?

The U.S. negative pressure wound therapy market size was estimated at USD 840 million in 2025 and is predicted to be worth around USD 1,620 million by 2035, growing at a CAGR of 6.79% from 2026 to 2035.

North America dominated the negative pressure wound therapy market in 2025. Negative pressure wound therapy is widely used in the North American region. The rising senior population and rising hospitals lead to the growth of the market. Negative pressure wound therapy is commonly provided with V.A.C. (Vacuum Assisted Closure) KCI, TX, USA system using a sealed open-spore gauze or spore, which is now commonplace in trauma and orthopedic departments. The majority of U.S. military casualties with wounds appeared in the United States with negative pressure wound therapy (NPWT) devices in place. In the Canadian community healthcare settings, single-use or disposable negative pressure wound therapy devices are used for the treatment. These factors help to the growth of the market in this region.

• In April 2025, RENASYS EDGE, a negative pressure wound therapy (NPWT) system in the United States, was launched by a medical technology company, Smith+Nephew. This system is designed to improve home-based care for patients who suffer from chronic wounds.

U.S. Negative Pressure Wound Therapy Market Trends

At the moment, the U.S. has the esstential NPWT market globally, benefiting from its tried and tested healthcare system, especially high diabetes rates and high growth rates of clients over the age of 65. Withover 37 million Americans living with diabetes, the morbidity of diabetic foot ulcers and chronic wounds creates demand for advanced wound therapies and NPWT. High reimbursement rates from the Center for Medicare & Medicaid Services, and companies like 3M (Acelity), Cardinal Health, and Smith & Nephew, maintains NPWT growth rates. In addition, there is increasing patient demand for portable and home-care NPWT devices to wound care outside of a professional clinical practice.

What Makes Asia Pacific the Fastest-Growing Market?

Asia Pacific is estimated to be the fastest-growing during the forecast period of 2025-2034. China is the leading country in the demand for advanced wound care technologies. The Chinese herbal medicines put together with negative pressure wound therapy (NPWT) may effectively functionally promotewound healing, shorten disease course in patients, and reduce inflammation. These factors help to grow the negative pressure wound therapy market in this region.

Japan Negative Pressure Wound Therapy Market Trends

The NPWT market in Japan continues to grow steadily, spurred on by its super-aged society—over 29% of the population is 65 years of age or older—and the increasing incidents of chronic wounds, pressure ulcers, and surgical site infections. The Japanese healthcare system is known for its universal coverage and high standards, and it encourages advanced wound care technology as part of the current healthcare standard. The market was further accelerated by the increasing acceptance of NPWT as part of clinical practice by both healthcare professionals and patients. In addition, the significant uptake in investments toward R&D and medical robotics offer new opportunities for NPWT innovation within Japan.

How is the Opportunistic Rise of Europe in the Negative Pressure Wound Therapy Market?

Europe is expected to grow at a significant rate during the forecast period. This is mainly due to the increased awareness regarding advanced wound care solutions, favorable reimbursement policies, and the rising prevalence of diabetic ulcers and pressure sores. Regulatory support from bodies like the European Medicines Agency (EMA) helps to drive market growth even more, promoting the adoption of NPWT technologies. Germany, the UK, and France are leading players in the region as these countries are seen increasingly integrating NPWT into standard care protocols.

Germany Negative Pressure Wound Therapy Market Trends

Germany is the largest economy in Europe and its Negative Pressure Wound Therapy market is well established and technologically advanced with it having an increasingly older population and with Hospital resources dedicated to its clinical efficacy and patient outcomes. The German government has policies and reimbursement practices that promote NPWT use in Hospitals and outpatient care procedures via its publicly funded Statutory Health Insurance (SHI) system, thereby making NPWT a common treatment practice. German clinicians are evidence-based and continually evaluate the best use of advanced therapies within their practice.

What Potentiates the Negative Pressure Wound Therapy Market in Latin America?

The market in Latin America is driven by various factors such as the increasing prevalence of chronic diseases like diabetes, the rising number of surgical procedures, and various advancements in wound care technologies. The region is also witnessing continuous innovation in NPWT devices, such as portable and single-use devices, which have expanded their application and convenience even more. Advanced features like integrated sensors, automated pressure adjustments, and connectivity with healthcare systems are also gaining traction, driving innovation in the market.

What Opportunities Exist in the Middle East & Africa for the Market?

The Middle East & Africa (MEA) presents immense opportunities in the negative pressure wound therapy market, driven by various factors like increasing healthcare investments, rising awareness of advanced wound care, and a growing incidence of chronic wounds. The region is implementing various incentives and policies to help improve healthcare infrastructure. Countries like South Africa and the UAE are leading players in the market as they are quick to adopt NPWT technologies.

Value Chain Analysis

• Raw Material and Component Sourcing
  This stage involves sourcing medical-grade polymers, films, foams, tubes, as well as electronic components that are required for wound dressing and therapies.
  Key Players: 3M, Saint Gobain, Dupont
• Manufacturing Process
  This stage includes the assembly of NPWT pumps, dressing kits, canisters, and tubing sets.
  Key Players: Convantec, Medela, Cardinal Health

Negative Pressure Wound Therapy Market Companies

• Acelity (now part of 3M): As the market leader, Acelity (through its KCI subsidiary) developed the widely recognized V.A.C. (Vacuum-Assisted Closure) therapy system, which set the standard for NPWT and is extensively supported by clinical evidence.
• ConvaTec Inc.: ConvaTec strengthens its market position by offering portable, single-use NPWT devices like the Avelle system, which cater to the growing demand for cost-effective, home-care solutions.
• Cardinal Health: This company focuses on improving the cost-effectiveness and accessibility of NPWT through a broad portfolio of devices suitable for both hospital and home care settings.
• Cork Medical: Cork Medical offers a range of NPWT systems, including the Nisus and Versa devices, that are known for their powerful flow rates, portability, and user-friendly design.
• DeRoyal Industries, Inc.: DeRoyal contributes to the market as a manufacturer of various medical and surgical products, including NPWT devices and accessories.
• Genadyne Biotechnologies Inc: Genadyne provides cost-effective and innovative NPWT solutions, such as the XLRRS pump system, which are primarily used in both hospital and homecare settings.
• Invacare Corporation: Invacare is primarily known as a manufacturer of home and long-term care medical equipment, but is less prominent as a specific innovator or major player in the highly specialized NPWT device market compared to companies like 3M/Acelity or Smith & Nephew.

Other Major Key Players

• 3M
• Molnlycke Health Care
• Paul Hartmann AG
• Smith+Nephew
• Sanoma Pharmaceuticals
• Tally Group Ltd

Segments Covered in the Report

By Product Type

• Conventional NPWT Devices
• Single-use NPWT Devices
• NPWT Accessories

By Wound Type

• Chronic Wounds
  • Pressure Ulcer
  • Diabetic Foot Ulcer
  • Venous Leg Ulcer
  • Others
• Acute Wounds
  • Surgical & Traumatic Wounds
  • Burns

By End-use Type

• Hospital
• Specialty Clinics
• Home Healthcare
• Others

By Geography

• North America
• Asia Pacific
• Europe
• Latin America
• Middle East & Africa